Down-regulation of S100A1 protein in patients with metabolic syndrome and its association with zinc-a2-glycoprotein

Down-regulation of S100A1 protein in patients with metabolic syndrome and its association with zinc-a2-glycoprotein


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: ثریا خیروری , محمد علی زاده

کلمات کلیدی: Metabolic syndrome, zinc-a2-glycoprotein, S100A1

نشریه: 31229 , 0 , 0 , 2017

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله ثریا خیروری
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه دانشکده تغذیه
کد مقاله 62093
عنوان فارسی مقاله Down-regulation of S100A1 protein in patients with metabolic syndrome and its association with zinc-a2-glycoprotein
عنوان لاتین مقاله Down-regulation of S100A1 protein in patients with metabolic syndrome and its association with zinc-a2-glycoprotein
ناشر 3
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت https://www.ncbi.nlm.nih.gov/pubmed/28825380

خلاصه مقاله
hide/show

Abstract Objectives: It has been proposed that zinc-a2-glycoprotein and S100A1 are possibly linked to the development of lipogenesis and obesity. We aimed to measure serum levels of S100A1 and zinc-a2-glycoprotein in patients with metabolic syndrome and investigate any associations of these two novel peptides with each other or components of metabolic syndrome. Methods: Forty-four patients with metabolic syndrome and the equivalent number of healthy controls participated in this study. The participants’ body mass index, waist circumference, systolic and diastolic blood pressure were measured. Serum levels of low- and high-density lipoprotein cholesterol, total cholesterol, triglyceride, fasting blood sugar, insulin, zinc-a2-glycoprotein and S100A1 protein were determined. Results: Higher levels of anthropometric and lipid indices, metabolic factors and also SBP and DBP were observed in the metabolic syndrome group. Serum S100A1 levels were significantly lower in the metabolic syndrome group than the control group (P¼0.008). There was a strong positive correlation between serum zinc-a2-glycoprotein and S100A1 levels (r¼0.80, P<0.0001). Serum levels of both S100A1 (P¼0.03) and zinc-a2-glycoprotein (P¼0.02) were potentially higher in subjects with hypertension than those with normal blood pressure, though these were found as part of multiple testing. Conclusion: The results indicate that changes in the circulating level of S100A1 protein occur in metabolic syndrome patients. The strong correlation between serum zinc-a2-glycoprotein and S100A1 might suggest that production or release of these two proteins could be related mechanistically.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
ثریا خیروریدوم
محمد علی زادهسوم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
S100A1-metabolic syndrom.pdf1396/10/20223413دانلود